DEBUT BIOTECHNOLOGY, INC. — Form D
DEBUT BIOTECHNOLOGY, INC. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-05. The offering totals $22.6M, of which $22.6M was reported sold. Industry: Other Technology.
Offering
- Filed: 2021-08-05
- Form: D
- Accession: 0001798639-21-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $22.6M
- Amount sold: $22.6M
- Minimum investment: $1
- Investors: 12
- Date of first sale: 2021-07-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-408972
Issuer
- Name: DEBUT BIOTECHNOLOGY, INC.
- CIK: 0001798639
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 6330 NANCY RIDGE DR. UNIT 106, SAN DIEGO, CA, 92121
- Phone: (619) 432-5177
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| DANIEL A PHILLIPS | Director | SAN DIEGO, CA |
| JOSHUA BRITTON | Director | SAN DIEGO, CA |
| JOSHUA BRITTON | Executive Officer | SAN DIEGO, CA |
| CORINNA A CHEN | Director | SAN DIEGO, CA |
| GREGORY A WEISS | Executive Officer | SAN DIEGO, CA |
| Cain A McClary | Director | San Diego, CA |
Other filings by this issuer (3)
More